http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-950018033-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-14 |
| filingDate | 1993-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1995-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-950018033-A |
| titleOfInvention | Nucleoside compound and preparation method thereof |
| abstract | The present invention provides novel nucleoside compounds of the general formula (I) or pharmaceutically acceptable salts thereof which are effective as antiviral agents.n n n n n n n n Wherein R 1 represents a saturated or unsaturated alkyl group having 6 to 22 carbon atoms, R 2 represents a saturated or unsaturated alkyl group having 12 to 20 carbon atoms, R 3 and R 4 are a hydrogen atom or a hydroxyl group, and B is It is one of the bases represented by general formula (a),n n n n n n n n Wherein R 5 is a hydrogen atom, a halogen atom or a hydroxy, amino, mercapto, alkyl amino group having 1 to 4 carbon atoms, R 6 is a hydrogen atom, a halogen atom or an amino group, W is a nitrogen atom or CR 8 , Wherein R 8 is a hydrogen atom, a halogen atom or an amino group, an alkyl group having 1 to 4 carbon atoms.)n n n The nucleoside compounds of the present invention have less inactivation by metabolism and have favorable transmembrane properties, thus exhibiting excellent antiviral effects. |
| priorityDate | 1993-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.